New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2014
12:06 EDTTSRO, FPRXFive Prime could be close to collaboration deal, says Wells Fargo
Wells Fargo says that after speaking to management, it believes Five Prime Therapeutics (FPRX) may be close to finalizing a collaboration deal with a pharma company relating to its preclinical immunooncology targets. Wells expects a near-term partnership to drive shares of Five Prime higher, and notes TESARO (TRSO) is up around 30% today following its collaboration announcement.
News For FPRX;TSRO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2015
10:02 EDTFPRXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:56 EDTFPRXFive Prime initiated with a Buy at Citi
Citi analyst Kennen MacKay calls Five Prime Therapeutics a promising early stage immuno-oncology company with a validated drug discovery platform. He started shares with a Buy rating and $33 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use